Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
18 11 2022
Historique:
received: 04 08 2022
accepted: 03 11 2022
pubmed: 19 11 2022
medline: 23 11 2022
entrez: 18 11 2022
Statut: epublish

Résumé

Antibodies against the carboxy-terminal section of the membrane-proximal external region (C-MPER) of the HIV-1 envelope glycoprotein (Env) are considered as nearly pan-neutralizing. Development of vaccines capable of producing analogous broadly neutralizing antibodies requires deep understanding of the mechanism that underlies C-MPER recognition in membranes. Here, we use the archetypic 10E8 antibody and a variety of biophysical techniques including single-molecule approaches to study the molecular recognition of C-MPER in membrane mimetics. In contrast to the assumption that an interfacial MPER helix embodies the entire C-MPER epitope recognized by 10E8, our data indicate that transmembrane domain (TMD) residues contribute to binding affinity and specificity. Moreover, anchoring to membrane the helical C-MPER epitope through the TMD augments antibody binding affinity and relieves the effects exerted by the interfacial MPER helix on the mechanical stability of the lipid bilayer. These observations support that addition of TMD residues may result in more efficient and stable anti-MPER vaccines.

Identifiants

pubmed: 36400835
doi: 10.1038/s42003-022-04219-6
pii: 10.1038/s42003-022-04219-6
pmc: PMC9674588
doi:

Substances chimiques

HIV Envelope Protein gp41 0
HIV Antibodies 0
Epitopes 0
Lipid Bilayers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1265

Informations de copyright

© 2022. The Author(s).

Références

J Am Chem Soc. 2018 Jan 10;140(1):34-37
pubmed: 29277995
Annu Rev Immunol. 2016 May 20;34:635-59
pubmed: 27168247
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1624-39
pubmed: 18222166
Annu Rev Biophys Biomol Struct. 2006;35:177-98
pubmed: 16689633
Nat Commun. 2019 Jan 8;10(1):78
pubmed: 30622256
J Virol. 2018 Mar 28;92(8):
pubmed: 29386285
J Am Chem Soc. 2018 Jul 5;140(26):8246-8259
pubmed: 29888593
Nat Commun. 2019 Nov 26;10(1):5389
pubmed: 31772165
FEBS Lett. 2011 Nov 16;585(22):3533-7
pubmed: 22020218
Vaccine. 2018 Oct 1;36(41):6191-6201
pubmed: 30197285
J Mol Model. 2019 Feb 26;25(3):76
pubmed: 30806797
Immunity. 2012 Sep 21;37(3):412-25
pubmed: 22999947
J Mol Biol. 2014 Mar 6;426(5):1095-108
pubmed: 24075869
J Virol. 2009 Nov;83(22):11588-98
pubmed: 19726514
Methods Mol Biol. 2019;1886:117-151
pubmed: 30374865
Curr Opin HIV AIDS. 2017 May;12(3):250-256
pubmed: 28422789
J Virol. 2008 Sep;82(18):8986-96
pubmed: 18596094
Chem Phys Lipids. 2014 Jul;181:40-55
pubmed: 24704587
Protein Cell. 2018 Jul;9(7):596-615
pubmed: 29667004
Cell Host Microbe. 2019 Nov 13;26(5):623-637.e8
pubmed: 31653484
FEBS Lett. 2006 Jan 23;580(2):505-9
pubmed: 16388805
J Cell Biol. 1988 Nov;107(5):1677-87
pubmed: 3053734
Sci Rep. 2021 Jan 14;11(1):1278
pubmed: 33446748
Elife. 2021 Apr 19;10:
pubmed: 33871352
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3477-81
pubmed: 8622961
Vaccine. 2015 Feb 11;33(7):861-8
pubmed: 25559188
AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1757-65
pubmed: 11788027
Immunity. 2008 Jan;28(1):52-63
pubmed: 18191596
Nature. 2012 Nov 15;491(7424):406-12
pubmed: 23151583
Sci Immunol. 2017 Jan 27;2(7):
pubmed: 28783671
J Biol Chem. 2015 May 22;290(21):12999-3015
pubmed: 25787074
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9057-62
pubmed: 19458040
Biophys J. 2012 Jan 4;102(1):L01-3
pubmed: 22225813
Nature. 2009 May 21;459(7245):379-85
pubmed: 19458714
Sci Rep. 2016 Dec 01;6:38177
pubmed: 27905530
Biochim Biophys Acta. 2010 Apr;1798(4):741-9
pubmed: 20044974
J Mol Biol. 2005 Apr 1;347(3):597-606
pubmed: 15755453
J Virol. 2014 Nov;88(22):13367-77
pubmed: 25210180
Ann Biomed Eng. 2020 Jul;48(7):1991-2001
pubmed: 31832930
Biochemistry. 1996 Feb 6;35(5):1383-6
pubmed: 8634267
Biophys J. 2010 Sep 8;99(5):1387-96
pubmed: 20816050
AIDS. 2005 Nov 4;19(16):1725-37
pubmed: 16227780
J Mol Biol. 2007 Feb 2;365(5):1533-44
pubmed: 17125793
Sci Transl Med. 2014 Jul 2;6(243):243ra88
pubmed: 24990883
J Biol Chem. 1992 Feb 5;267(4):2664-70
pubmed: 1733963
Annu Rev Biophys Biomol Struct. 2001;30:105-28
pubmed: 11340054
Science. 2016 Jul 8;353(6295):172-175
pubmed: 27338706
Cell Rep. 2020 Apr 28;31(4):107583
pubmed: 32348769
Science. 2016 Mar 4;351(6277):1043-8
pubmed: 26941313
J Virol. 2012 Mar;86(6):2930-41
pubmed: 22238313
J Virol. 2000 Sep;74(17):8038-47
pubmed: 10933713
Microbiol Mol Biol Rev. 2008 Mar;72(1):54-84, table of contents
pubmed: 18322034
Biophys J. 1996 May;70(5):2437-41
pubmed: 9172770
J Virol. 1999 Mar;73(3):2469-80
pubmed: 9971832
ACS Infect Dis. 2020 Aug 14;6(8):2155-2168
pubmed: 32584020
J Virol. 2015 May;89(10):5264-75
pubmed: 25673728
Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22556-22566
pubmed: 31624123
PLoS Pathog. 2017 Feb 22;13(2):e1006212
pubmed: 28225819
J Biol Chem. 1984 Nov 10;259(21):13253-61
pubmed: 6490655
Biophys J. 2017 Sep 19;113(6):1301-1310
pubmed: 28797705
J Biol Chem. 2014 Mar 7;289(10):6565-6580
pubmed: 24429284
Prog Biophys Mol Biol. 1999;72(4):367-405
pubmed: 10605294
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8892-E8899
pubmed: 30185554
Biochemistry. 1997 Jun 17;36(24):7457-63
pubmed: 9200694
Adv Protein Chem Struct Biol. 2015;99:15-54
pubmed: 26067815
J Biol Chem. 2002 Jun 14;277(24):21776-85
pubmed: 11929877
Immunity. 2019 Mar 19;50(3):677-691.e13
pubmed: 30876875
J Biol Chem. 2004 May 14;279(20):21576-88
pubmed: 15020585
J Biol Chem. 2004 Apr 30;279(18):18526-34
pubmed: 14981088
Cell Rep. 2020 Aug 18;32(7):108037
pubmed: 32814041
Biochim Biophys Acta. 2008 Nov;1778(11):2627-32
pubmed: 18782557
J Virol. 2016 Sep 12;90(19):8875-90
pubmed: 27466419
Immunity. 2016 Jan 19;44(1):21-31
pubmed: 26777395
J Biol Chem. 2006 Dec 22;281(51):39598-606
pubmed: 17050535
Biophys J. 2008 Sep 15;95(6):2792-805
pubmed: 18515383
Cell Rep. 2018 Feb 13;22(7):1798-1809
pubmed: 29444432
Viruses. 2020 Oct 23;12(11):
pubmed: 33114242
Biochim Biophys Acta Biomembr. 2021 Nov 1;1863(11):183723
pubmed: 34352242
J Virol. 2016 Jun 10;90(13):5899-5914
pubmed: 27053554
J Membr Biol. 2005 Dec;208(3):193-202
pubmed: 16604469
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):9972-7
pubmed: 10963664
PLoS Pathog. 2014 Jul 24;10(7):e1004271
pubmed: 25058619
Biophys J. 2003 Dec;85(6):3769-80
pubmed: 14645067

Auteurs

Johana Torralba (J)

Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.

Igor de la Arada (I)

Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.

Angélica Partida-Hanon (A)

Institute of Physical Chemistry "Rocasolano" (IQFR-CSIC), Serrano 119, E-28006, Madrid, Spain.

Edurne Rujas (E)

Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain.
Pharmacokinetic, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.
Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.

Madalen Arribas (M)

Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.

Sara Insausti (S)

Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.

Claire Valotteau (C)

Laboratoire Adhesion et Inflammation, INSERM U1067, CNRS UMR 7333, Aix-Marseille Université, Turing Centre for Living systems, Marseille, France.

Javier Valle (J)

Laboratory of Proteomics and Protein Chemistry, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Dr. Aiguader 88, 08003, Barcelona, Spain.

David Andreu (D)

Laboratory of Proteomics and Protein Chemistry, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Dr. Aiguader 88, 08003, Barcelona, Spain.

José M M Caaveiro (JMM)

Laboratory of Global Healthcare, School of Pharmaceutical Sciences, Kyushu University, Fukuoka, 819-0395, Japan.

María Angeles Jiménez (MA)

Institute of Physical Chemistry "Rocasolano" (IQFR-CSIC), Serrano 119, E-28006, Madrid, Spain.

Beatriz Apellániz (B)

Department of Physiology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006, Vitoria-Gasteiz, Spain. beatriz.apellaniz@ehu.eus.

Lorena Redondo-Morata (L)

Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017/CIIL-Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. lorena.redondo-morata@inserm.fr.

José L Nieva (JL)

Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain. joseluis.nieva@ehu.eus.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain. joseluis.nieva@ehu.eus.

Articles similaires

1.00
Immunoconjugates Humans Antibodies, Bispecific Receptor, ErbB-2 Cell Line, Tumor

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4

James Baxter, Ch Julián Villabona-Arenas, Robin N Thompson et al.
1.00
Humans HIV-1 HIV Infections CD4-Positive T-Lymphocytes CD4 Lymphocyte Count
RNA, Long Noncoding Humans Virus Latency Monocytes HIV-1
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Classifications MeSH